Buscar
01/09/2025
ANCA associated pulmonary fibrosis: vasculitis or not vasculitis
Codes-Méndez, H, Castillo, D, Moya-Alvarado, P, Giménez-Palleiro, A, Castellvi, I. ANCA associated pulmonary fibrosis: vasculitis or not vasculitis. CURRENT OPINION IN PULMONARY MEDICINE. 2025; 31(5)DOI:10.1097/MCP.0000000000001187. PMID:40548517. IF:2.800(Q2/5D).
01/08/2025
Persistent Blood Eosinophilia and Eosinopenia: Relationship with Outcomes in Bronchiectasis
Oscullo, G, Bekki, A, Olveira, C, Girón, R, García-Clemente, M, Maíz, L, Sibila, O, Golpe, R, Rodríguez-Hermosa, JL, Barreiro, E, Méndez, R, Prados, C, Rodríguez-López, J, de la Rosa, D, Martínez-García, MA. Persistent Blood Eosinophilia and Eosinopenia: Relationship with Outcomes in Bronchiectasis. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(8)DOI:10.1016/j.arbres.2025.01.018. PMID:39956702. IF:9.200(Q1/1D).
01/08/2025
Genome-wide Association Study of Asthma Exacerbations in the Spanish Population
Martin-Gonzalez, E, Perez-Garcia, J, Martin-Almeida, M, Hernández-Pérez, JM, González-Pérez, R, Sardón, O, Pérez-Pérez, JA, González-Carracedo, MA, Poza-Guedes, P, Sánchez-Machín, I, Mederos-Luis, E, Corcuera, P, López-Fernández, L, Román-Bernal, B, González-García, LM, Cruz, MJ, González-Barcala, FJ, Martínez-Rivera, C, Mullol, J, Muñoz, X, Olaguibel, JM, Plaza, V, Quirce, S, Valero, A, Sastre, J, del Pozo, V, Villar, J, Lorenzo-Diaz, F, Pino-Yanes, M. Genome-wide Association Study of Asthma Exacerbations in the Spanish Population. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(8)DOI:10.1016/j.arbres.2025.03.012. PMID:40187921. IF:9.200(Q1/1D).
01/08/2025
Sleep-disordered Breathing in Patients with Chronic Obstructive Pulmonary Disease: Prevalence and Outcomes
Marin, JM, Soriano, JB, Marin-Oto, M, De-Torres, JP, Seijo, LM, Cabrera, C, Solanes, I, Martinez, C, Toledo-Pons, N, Feu, N, Amado, C, Vigil, L, Celli, BR, Casanova, C. Sleep-disordered Breathing in Patients with Chronic Obstructive Pulmonary Disease: Prevalence and Outcomes. Annals of the American Thoracic Society. 2025; 22(8)DOI:10.1513/AnnalsATS.202501-030OC. PMID:40208311. IF:5.400(Q1/2D).
01/07/2025
DUPILUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE AND ASTHMA CONTROL IN PATIENTS WITH AND WITHOUT COEXISTING TYPE 2 CONDITIONS: RESULTS FROM THE RAPID STUDY
Mosnaim, GS, Price, D, Côté, A, Plaza, V, Xia, CM, Awad, H, Kwah, J. DUPILUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE AND ASTHMA CONTROL IN PATIENTS WITH AND WITHOUT COEXISTING TYPE 2 CONDITIONS: RESULTS FROM THE RAPID STUDY. VALUE IN HEALTH. 2025; 28(6)DOI:. PMID:. IF:6.000(Q1/1D).
01/05/2025
Real-World Evidence for Fixed Triple Therapy With Beclomethasone/Formoterol/Glycopyrronium in Asthma Patients With Concomitant COPD: Six-Month Results of Trimaximize
Gessner, C, Bogoevska,, Russell, R, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Fritz, C, Hahn, A, Trinkmann, F. Real-World Evidence for Fixed Triple Therapy With Beclomethasone/Formoterol/Glycopyrronium in Asthma Patients With Concomitant COPD: Six-Month Results of Trimaximize. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 211DOI:10.1164/ajrccm.2025.211.Abstracts.A3500. PMID:. IF:19.400(Q1/1D).
01/05/2025
Mortality Predictors in Thoracic Sarcoidosis: Results From SARCO-1 Registry
Torres, JS, Ramos, D, Francesqui, J, De Miguel, EB, Villar, A, Florez, P, Balcells, E, Pinillos-Robles, E, Castaño, G, Mayoral, RG, Muñiz, BL, Soler-Sampere, M, Castillo, D, Rafecas-Codern, A, Mariscal, P, Millan-Billi, P, Portillo, K, Hernandez, F. Mortality Predictors in Thoracic Sarcoidosis: Results From SARCO-1 Registry. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 211DOI:10.1164/ajrccm.2025.211.Abstracts.A1842. PMID:. IF:19.400(Q1/1D).
01/05/2025
Phenotype Analysis of Chronic Bronchial Infection Patients on Nebulized Antibiotic Therapy: A Multicenter Retrospective Cohort Study in Spain (INBREATHING Study)
Gonzalez, J, Moreno, BR, Benítez, I, Erro, M, Burgos, J, Sayés, A, García, EJ, Pou, C, Castañon, R, Navarro, A, de las Uentes, AM, Lakhani, JS, Hernández, A, Manzano, C, Santisteve, S, Monge, A, Moix, AM, Sánchez-Cucó, A, Alcaide, A, Tajos, JD, Barbe, F, Suárez, G, de la Rosa, D. Phenotype Analysis of Chronic Bronchial Infection Patients on Nebulized Antibiotic Therapy: A Multicenter Retrospective Cohort Study in Spain (INBREATHING Study). AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 211DOI:10.1164/ajrccm.2025.211.Abstracts.A5149. PMID:. IF:19.400(Q1/1D).
01/05/2025
Dupilumab Improves Health-related Quality of Life and Asthma Control in Patients With and Without Coexisting Type 2 Conditions: Results From the RAPID Study
Cote, A, Mosnaim, GS, Lugogo, NL, Price, D, Plaza, V, Changming, X, Awad, H, Kwah, J. Dupilumab Improves Health-related Quality of Life and Asthma Control in Patients With and Without Coexisting Type 2 Conditions: Results From the RAPID Study. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 211DOI:10.1164/ajrccm.2025.211.Abstracts.A1399. PMID:. IF:19.400(Q1/1D).
01/04/2025
Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry
Oscullo, G, Méndez, R, Olveira, C, Girón, R, García-Clemente, M, Máiz, L, Sibila, O, Golpe, R, Rodríguez-Hermosa, J, Barreiro, E, Prados, C, Rodríguez-López, JL, de la Rosa-carrillo, D, Martinez-García, MA. Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(4)DOI:10.1016/j.arbres.2025.02.015. PMID:40180519. IF:9.200(Q1/1D).
01/04/2025
Unraveling the Molecular Mechanisms of OSA-Related Cardiovascular Event Recurrence: A Post Hoc Analysis From the ISAACC Study
Zapater, A, Pinilla, L, Gracia-Lavedan, E, Targa, A, Torres, G, Mínguez, O, Pascual, L, Cortijo, A, Martínez, D, Benítez, ID, García-Hidalgo, MC, De Batlle, J, Abad, J, Duran-Cantolla, J, Urrutia, A, Mediano, O, Masdeu, MJ, Ordax-Carbajo, E, Masa, JF, De la Peña, M, Mayos, M, Coloma, R, Montserrat, JM, Chiner, E, Roncero, A, Sanz-Rubio, D, Barbé, F, Sánchez-de-la-Torre, M. Unraveling the Molecular Mechanisms of OSA-Related Cardiovascular Event Recurrence: A Post Hoc Analysis From the ISAACC Study. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(4)DOI:10.1016/j.arbres.2024.09.008. PMID:39438203. IF:9.200(Q1/1D).
01/04/2025
Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial
Bermudo-Peloche, G, Del Rio, B, Vicens-Zygmunt, V, Bordas-Martinez, J, Hernández, M, Valenzuela, C, Laporta, R, Bobillo, JR, Portillo, K, Millán-Billi, P, Balcells, E, Badenes-Bonet, D, Bolivar, S, Rodríguez-Portal, JA, Ramirez, CL, Tomás, L, Roitegi, KFD, Sellarés, J, Castillo, D, González, J, Barril, S, Gutiérrez-Rodríguez, Y, Caballero, P, Alarcon, J, Peñafiel, J, Sanz-Santos, J, Blavia, R, Caupena, C, Segovia, P, Santos-Pérez, S, Ferrer-Artola, A, Badia, MB, Hereu, P, Fuentes, M, Montes-Worboys, A, Franquet, T, Luburich, P, Molina-Molina, M. Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial. EUROPEAN RESPIRATORY JOURNAL. 2025; 65(4)DOI:10.1183/13993003.02249-2024. PMID:40154560. IF:21.000(Q1/1D).
21/03/2025
Machine learning allows robust classification of lung neoplasm tissue using an electronic biopsy through minimally-invasive electrical impedance spectroscopy
Company-Se, G, Pajares, V, Rafecas-Codern, A, Riu, PJ, Rosell-Ferrer, J, Bragós, R, Nescolarde, L. Machine learning allows robust classification of lung neoplasm tissue using an electronic biopsy through minimally-invasive electrical impedance spectroscopy. Scientific Reports. 2025; 15(1)DOI:10.1038/s41598-025-94826-0. PMID:40119130. IF:3.900(Q1/2D).
01/01/2025
Erratum to 'Cough severity visual analog scale scores and quality of life in patients with refractory or unexplained chronic cough' [Respir Investig 62 (6) (2024), 987-994]
Domingo, C, Quirce, S, Dávila, I, Crespo-Lessman, A, Arismendi, E, De Diego, A, González-Barcala, FJ, de Llano, LP, Cea-Calvo, L, Sanchez-Jareño, M, López-Cotarelo, P, Puente-Maestu, L. Erratum to 'Cough severity visual analog scale scores and quality of life in patients with refractory or unexplained chronic cough' [Respir Investig 62 (6) (2024), 987-994]. Respiratory Investigation. 2025; 63(1)DOI:10.1016/j.resinv.2024.12.004. PMID:39667093. IF:(Q/D).
01/01/2025
Minimally-invasive electrical impedance spectroscopy in lung tissue: present and future trends
Riu, PJ, Company-Se, G, Codern, AR, Castany, AF, Pajares, V, Rosell, J, Bragós, R, Nescolarde, L. Minimally-invasive electrical impedance spectroscopy in lung tissue: present and future trends. INTERNATIONAL CONFERENCE ON ELECTRICAL BIOIMPEDANCE, AND ELECTRICAL IMPEDANCE TOMOGRAPHY 2025, ICEBI EIT CNIBI 2025. 2025; 3014DOI:10.1088/1742-6596/3014/1/012004. PMID:. IF:(Q/D).
01/01/2025
Safety and Effectiveness of Allergen Immunotherapy in Patients with Severe Allergic Asthma
Tabar, AI, Delgado-Romero, J, González-Mancebo, E, Dominguez-Ortega, J, Soto-Retes, L. Safety and Effectiveness of Allergen Immunotherapy in Patients with Severe Allergic Asthma. Journal of Asthma and Allergy. 2025; 18DOI:10.2147/JAA.S546044. PMID:40994702. IF:3.000(Q2/4D).
01/11/2024
Mycobacterium branderi Diagnosed by CryoEBUS. A New Tool for Infection Diagnosis?
Codern, AR, Ruiz, VP, Mitjà, PS. Mycobacterium branderi Diagnosed by CryoEBUS. A New Tool for Infection Diagnosis?. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(11)DOI:10.1016/j.arbres.2024.06.012. PMID:39013726. IF:9.200(Q1/1D).
01/11/2024
Asthma Control According to GINA 2023: Does Changing the Criteria Improve Asthma Control?
Arismendi, E, Ribo, P, Garcia, A, Torrego, A, Bobolea, I, Casas-Saucedo, R, Palomino, R, Picado, C, Muñoz-Cano, R, Valero, A. Asthma Control According to GINA 2023: Does Changing the Criteria Improve Asthma Control?. Journal of Clinical Medicine. 2024; 13(22)DOI:10.3390/jcm13226646. PMID:39597790. IF:2.900(Q1/2D).
01/10/2024
Parasympathetic nervous system: A key role in control and mood disorders in patients with asthma
Soto-Retes, L, Milagro, J, Crespo-Lessmann, A, Curto, E, Medina, EFM, Bailon, R, Gil, E, Laguna, P, Plaza, V. Parasympathetic nervous system: A key role in control and mood disorders in patients with asthma. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 2024; 133(4)DOI:10.1016/j.anai.2024.07.022. PMID:39074657. IF:4.700(Q1/1D).
01/09/2024
The Gut-Airways Microbiome axis in COPD
Viglino, J, Perea, L, Garcia-Nuñez, M, Rodrigo-Troyano, A, Torrego, A, Domínguez, M, Miratlles, L, Quero, S, Willis, J, Saus, E, Gabaldón, T, Gea, J, Santos, MS, Agusti, A, Monsó, E, Sibila, O, Faner, R. The Gut-Airways Microbiome axis in COPD. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA3032. PMID:. IF:21.000(Q1/1D).
01/09/2024
Heterogeneity of comorbidities captured by European national severe asthma registries in SHARP CRC
Rink, S, Freeman, A, Bansal, AT, Bossios, A, Frankemoelle, B, Schleich, F, Sont, JK, Singh, M, Bieksiene, K, Bourdin, A, Canonica, GW, Csoma, Z, Gemicioglu, B, Grisle, I, Popovic, SG, Hromis, S, Korn, S, Kuna, P, Loureiro, C, Mihaltan, F, Porsbjerg, C, Ramos-Barbon, D, Renaud, L, Sergejeva, S, Ten Brinke, A, Yasinska, V, Zervas, E, Skrgat, S, Kurukulaaratchy, R. Heterogeneity of comorbidities captured by European national severe asthma registries in SHARP CRC. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA1763. PMID:. IF:21.000(Q1/1D).
01/09/2024
Initial data analysis of the SHARP CRC patient population reveals a large heterogeneity among European patients with severe asthma
Fouka, E, Bansal, AT, Jaun, F, Håkansson, KEJ, Bieksiene, K, Bourdin, A, Butler, M, Canonica, GW, Csoma, Z, Dahlén, B, Gemicioglu, B, Grisle, I, Heaney, L, Heffler, E, Hromis, S, Kuna, P, Leuppi, J, Louis, R, Oureiro, C, Lúoviksdóttir, D, Mihaltan, F, Popovic, SG, Ramos-Barbon, D, Sedlak, V, Sergejeva, S, Skrgat, S, Ten Brinke, A, Yasinska, V, Zervas, E, Schleich, F, Porsbjerg, C, Bossios, A. Initial data analysis of the SHARP CRC patient population reveals a large heterogeneity among European patients with severe asthma. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA4008. PMID:. IF:21.000(Q1/1D).
01/09/2024
European physician perspectives on multimorbidity in severe asthma: findings from SHARP CRC
Rink, S, Freeman, A, Bansal, AT, Bossios, A, Frankemölle, B, Schleich, F, Sont, JK, Singh, M, Bieksiene, K, Bourdin, A, Canonica, GW, Csoma, Z, Gemicioglu, B, Grisle, I, Popovic, SG, Hromis, S, Korn, S, Kuna, P, Loureiro, C, Mihaltan, F, Porsbjerg, C, Ramos-Barbon, D, Renaud, L, Sergejeva, S, Ten Brinke, A, Yasinska, V, Zervas, E, Skrgat, S, Kurukulaaratchy, R. European physician perspectives on multimorbidity in severe asthma: findings from SHARP CRC. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2149. PMID:. IF:21.000(Q1/1D).
01/09/2024
Clinical characteristics of severe asthma patients in Europe, according to the percentage of GDP spent on healthcare- a SHARP-CRC study
Jaun, F, Bánsal, AT, Fouka, E, Hakansson, KEJ, Bieksiene, K, Bourdin, A, Butler, M, Canonica, GW, Csoma, Z, Dahlén, B, Gemicioglu, B, Grisle, I, Heaney, L, Heffler, E, Hromis, S, Kuna, P, Mihaltan, F, Leuppi, JD, Loureiro, C, Louis, R, Luoviksdóttir, D, Ramos-Barbon, D, Popovic, SG, Samitas, K, Sedlak, V, Sergejeva, S, Skrat, S, Ten Brinke, A, Yasinska, V, Zervas, E, Schleich, F, Porsbjerg, C, Bossios, A. Clinical characteristics of severe asthma patients in Europe, according to the percentage of GDP spent on healthcare- a SHARP-CRC study. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA1248. PMID:. IF:21.000(Q1/1D).
01/09/2024
The SHARP CRC Health Economics Study. Simulation of the preventable costs of oral corticosteroids in severe asthmatics in eleven European countries
Bourdin, A, Bansal, AT, Di Matteo, S, Giacomo, CM, Heaney, B, Ten Brinke, A, Csoma, Z, Dahlen, B, Djukanovic, R, Heaney, L, Kuna, P, Heffler, E, Louis, R, Porsbjerg, C, Ramos-Barbon, D, Skrgat, S, Paulsson, T, Mascialino, B. The SHARP CRC Health Economics Study. Simulation of the preventable costs of oral corticosteroids in severe asthmatics in eleven European countries. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA1176. PMID:. IF:21.000(Q1/1D).
01/09/2024
Stoma Stent in a traqueotomy decanulation process. Experience in a cohort of patients with prolongued mechanical ventilation
Otero, ARP, Pujal, P, Rafecas, A, Panadero, C, Penacoba, P, Puy, C, Segura, M, Anton, PA. Stoma Stent in a traqueotomy decanulation process. Experience in a cohort of patients with prolongued mechanical ventilation. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2615. PMID:. IF:21.000(Q1/1D).
01/09/2024
Real-world effectiveness of switching to Benralizumab in patients with severe asthma in the Catalan population. Catalan Society of Pulmonology (SOCAP) Registry
Arismendi, E, Muñoz, M, Crespo, A, Ausin, P, Castillo, JA, Curto, E, Lapuente, A, Arguedas, AM, Martínez-Rivera, C, Monserrate, D, Muñoz, X, Ojanguren, I, Palones, E, Paredes, M, Pilia, F, Picado, C, Sabater, G, Sabadell, C, Sogo, A, Cañete, C. Real-world effectiveness of switching to Benralizumab in patients with severe asthma in the Catalan population. Catalan Society of Pulmonology (SOCAP) Registry. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA3926. PMID:. IF:21.000(Q1/1D).
01/09/2024
Molecular insights into hypoxic burden physiopathology in OSA: a proteomic perspective
Pinilla, L, Dodani, K, Benitez, I, Esmaeli, N, Gracia-Lavedán, E, Torres, G, Minguez, O, Martinez, D, Martínez-García, MA, Abad, J, Masdeu, MJ, Mediano, O, Muñoz, C, Cabriada, V, Duran-Cantolla, J, Mayos, M, Coloma, R, Montserrat, JM, De la Peña, M, Cano-Pumarega, I, Barbé, F, Azarbarzin, A, Sanchez-De-la-Torre, M. Molecular insights into hypoxic burden physiopathology in OSA: a proteomic perspective. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2693. PMID:. IF:21.000(Q1/1D).
01/09/2024
Improvement in lung function after six months of treatment with extrafine formulation single-inhaler triple therapy (efSITT) in patients with asthma-TriMaximize Study
Gessner, C, Bogoevska, V, Nachtigall, D, Russell, R, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Criée, CP, Trinkmann, F. Improvement in lung function after six months of treatment with extrafine formulation single-inhaler triple therapy (efSITT) in patients with asthma-TriMaximize Study. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2121. PMID:. IF:21.000(Q1/1D).
01/09/2024
Impact of extrafine formulation single-inhaler triple therapy on asthma control and treatment adherence after six months of treatment in patients with asthma-TriMaximize study
Greulich, T, Bogoevska, V, Nachtigall, D, Russell, R, Suppli, C, Wolfgang, U, Pohl, W, Plaza, V, Bourdin, A, Baumeister, S, Gessner, C. Impact of extrafine formulation single-inhaler triple therapy on asthma control and treatment adherence after six months of treatment in patients with asthma-TriMaximize study. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA3907. PMID:. IF:21.000(Q1/1D).
01/08/2024
Spanish Consensus on Remission in Asthma (REMAS)
Alvarez-Gutiérrez, FJ, Casas-Maldonado, F, Soto-Campos, G, Blanco-Aparicio, M, Delgado, J, Galo, AP, Quirce, S, Plaza, V. Spanish Consensus on Remission in Asthma (REMAS). ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(8)DOI:10.1016/j.arbres.2024.04.002. PMID:38697903. IF:9.200(Q1/1D).
01/06/2024
Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort
Millan-Billi, P, Castellví, I, Martinez-Martinez, L, Mariscal, A, Barril, S, D'Alessandro, M, Franquet, T, Castillo, D. Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(6)DOI:10.1016/j.arbres.2024.03.028. PMID:38644152. IF:9.200(Q1/1D).
01/06/2024
The impact of smoking on bronchiectasis and its comorbidities
de la Rosa-Carrillo, D, de Granda-Orive, JI, Cáceres, LD, Pereyra, FG, Moreno, BR, Martínez-Garcia, MA, Suárez-Cuartin, G. The impact of smoking on bronchiectasis and its comorbidities. Expert Review of Respiratory Medicine. 2024; 18(5)DOI:10.1080/17476348.2024.2369716. PMID:38888096. IF:2.700(Q2/5D).
01/06/2024
BASELINE CHARACTERISTICS OF PATIENTS WITH ASTHMA AND PRIOR ORAL SYSTEMIC CORTICOSTEROID USE INITIATING DUPILUMAB IN A REAL-WORLD REGISTRY (RAPID)
Lugogo, NL, Heffler, E, Plaza,, Hilberg, O, Xia, C, Nash, S, Pandit-Abid, N, Jacob-Nara, JA, Sacks, H, Rowe, PJ, Deniz, Y, Hardin, M, Reed, C, Soler, X. BASELINE CHARACTERISTICS OF PATIENTS WITH ASTHMA AND PRIOR ORAL SYSTEMIC CORTICOSTEROID USE INITIATING DUPILUMAB IN A REAL-WORLD REGISTRY (RAPID). VALUE IN HEALTH. 2024; 27(6)DOI:. PMID:. IF:6.000(Q1/1D).
01/05/2024
Unraveling the Enigma: Spain Takes a Pioneering Step With REPAIR in the World of Inhaled Antibiotics
de la Rosa-Carrillo, D, Miravitlles, M, Pomares, X, Martínez-García, MA. Unraveling the Enigma: Spain Takes a Pioneering Step With REPAIR in the World of Inhaled Antibiotics. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(5)DOI:10.1016/j.arbres.2024.01.007. PMID:38310073. IF:9.200(Q1/1D).
01/05/2024
Extrafine Formulation Single-inhaler Triple Therapy Improves Lung Function After Six Months of Treatment in Patients With Asthma: Trimaximize Study
Gessner, C, Bogoevska, V, Nachtigall, D, Russell, R, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Akyildiz, B, Trinkmann, F. Extrafine Formulation Single-inhaler Triple Therapy Improves Lung Function After Six Months of Treatment in Patients With Asthma: Trimaximize Study. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2024; 209DOI:. PMID:. IF:19.400(Q1/1D).
24/04/2024
Association between nailfold videocapillaroscopy findings and sKL-6 levels in patients with idiopathic inflammatory myopathies-related interstitial lung disease
Santos, CS, Tandaipan, JL, Castillo, D, Martínez, LM, Codes, H, Sainz, L, Magallares, B, Moya, P, Corominas, H, Alvarez, ED, Castellvi, I. Association between nailfold videocapillaroscopy findings and sKL-6 levels in patients with idiopathic inflammatory myopathies-related interstitial lung disease. RHEUMATOLOGY. 2024; 63DOI:10.1093/rheumatology/keae163.188. PMID:. IF:4.400(Q1/1D).
24/04/2024
The current practice in the diagnostic work-up of patients with hemoptysis of unknown etiology an international survey
Mondoni, M, Cefalo, J, Carlucci, P, Puci, M, Saderi, L, Degrassi, M, Fernandez, AT, Pajares, V, Bodtger, U, Sorino, C, Zagaria, MP, Solidoro, P, Centanni, S, Sotgiu, G. The current practice in the diagnostic work-up of patients with hemoptysis of unknown etiology an international survey. MINERVA MEDICA. 2024; DOI:10.23736/S0026-4806.24.09192-4. PMID:38695633. IF:4.700(Q/D).
02/02/2024
Utility of bronchoalveolar lavage for COVID-19: a perspective from the Dragon consortium
Tomassetti, S, Ciani, L, Luzzi, V, Gori, L, Trigiani, M, Giuntoli, L, Lavorini, F, Poletti, V, Ravaglia, C, Torrego, A, Maldonado, F, Lentz, R, Annunziato, F, Maggi, L, Rossolini, GM, Pollini, S, Para, O, Ciurleo, G, Casini, A, Rasero, L, Bartoloni, A, Spinicci, M, Munavvar, M, Gasparini, S, Comin, C, Cerinic, MM, Peired, A, Henket, M, Ernst, B, Louis, R, Corhay, JL, Nardi, C, Guiot, J. Utility of bronchoalveolar lavage for COVID-19: a perspective from the Dragon consortium. Frontiers in Medicine. 2024; 11DOI:10.3389/fmed.2024.1259570. PMID:38371516. IF:3.000(Q1/2D).
01/01/2024
Methodology Employed to Develop the Airway Mucus Secretion Test (T-SEC): A Questionnaire to Evaluate Airway Mucus Hypersecretion in Patients With Asthma
Palones E., García-Rivero J.L., Cisneros C., Almonacid-Sánchez C., Pérez-de Llano L., Plaza V., Crespo-Lessmann A.. Methodology Employed to Develop the Airway Mucus Secretion Test (T-SEC): A Questionnaire to Evaluate Airway Mucus Hypersecretion in Patients With Asthma. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(3)DOI:10.1016/j.arbres.2024.01.002. PMID:38290898. IF:9.200(Q1/1D).
01/01/2024
Archivos de Bronconeumologia 59 (2023) 63–65, (S0300289622004975), (10.1016/j.arbres.2022.07.011)
Palones E., Curto E., Pelegrí A., Arilla M., Solanes I., Crespo-Lessmann A.. Archivos de Bronconeumologia 59 (2023) 63–65, (S0300289622004975), (10.1016/j.arbres.2022.07.011). ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.11.007. PMID:38040573. IF:9.200(Q1/1D).
01/01/2024
Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients
Valverde-Monge M., Sánchez-Carrasco P., Betancor D., Barroso B., Rodrigo-Muñoz J.M., Mahillo-Fernández I., Arismendi E., Bobolea I., Cárdaba B., Cruz M.J., Del Pozo V., Domínguez-Ortega J., González-Barcala F.J., Olaguibel J.M., Luna-Porta J.A., Martínez-Rivera C., Mullol J., Muñoz X., Peleteiro-Pedraza L., Picado Valles C., Plaza V., Quirce S., Rial M.J., Soto-Retes L., Valero A., Sastre J.. Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.11.011. PMID:38042707. IF:9.200(Q1/1D).
01/01/2024
Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study
Cano-Jiménez, E, Gómez, AV, Segovia, EV, Barrenechea, MA, Torres, JS, Francesqui, J, Carroz, KP, Solis, AJS, Fernández, OA, González, ABL, Bordas-Martinez, J, Cesar, EC, Vilarnau, EB, Villegas, DC, Pardessus, AR, Fernández, CG, Moyano, MG, Gajate, AU, Hortas, AB, Molina-Molina, M. Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study. Erj Open Research. 2024; 10(1)DOI:10.1183/23120541.00405-2023. PMID:38410707. IF:4.000(Q1/2D).
01/01/2024
Ultrasound in the Study of Thoracic Diseases: Innovative Aspects
Romero, BR, Torrubiano, IV, Juan, JM, Frades, SH, Pallares, JP, Ruiz, VP, Pérez, AW, Ramos, HC, Viedma, EC. Ultrasound in the Study of Thoracic Diseases: Innovative Aspects. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.10.009. PMID:37996336. IF:9.200(Q1/1D).
01/01/2024
Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience
de-Torres, JP, Casanova, C, Marín, JM, Cabrera, C, Marín, M, Ezponda, A, Cosio, BG, Martínez, C, Solanes, I, Fuster, A, Calle, M, Gotera, C, Feu-Collado, N, Marin, A, Alcaide, AB, Sangro, M, Bastarrika, G, Celli, BR. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.10.002. PMID:37925245. IF:9.200(Q1/1D).
01/01/2024
Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort
Betancor, D, Otal, M, Olaguibel, JM, Rodrigo-Muñoz, JM, Puebla, MJA, Arismendi, E, Barranco, P, Barroso, B, Bobolea,, Cárdaba, B, Cruz, MJ, Curto, E, Del Pozo,, Domínguez-Ortega, J, González-Barcala, FJ, Luna-Porta, JA, Martínez-Rivera, C, Mullol, J, Muñoz, X, Picado, C, Plaza,, Quirce, S, Rial, MJ, Roibás-Veiga,, Soto-Retes, L, Valero, A, Valverde-Monge, M, Sastre, J. Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2024; 34(3)DOI:10.18176/jiaci.0966. PMID:38888581. IF:4.800(Q1/1D).
01/01/2024
Use of Triple Therapy in Asthma: The GEMAFORUM V Task Force
Plaza, V, Trigueros, JA, Carretero, JA, Arranz, IO, Chicote, JMV, Sánchez, CA, Tomás, JB, Serrano, CC, Juncal, LD, Domínguez-Ortega, J, Rivero, JF, Campos, JGS, Fernández, EM, Martinez, S, Lacomba, JM, Quirce, S. Use of Triple Therapy in Asthma: The GEMAFORUM V Task Force. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2024; 34(4)DOI:10.18176/jiaci.0975. PMID:38334050. IF:4.800(Q1/1D).
18/12/2023
Bronchoalveolar cytokine profile differentiates Pulmonary Langerhans cell histiocytosis patients from other smoking-related interstitial lung diseases
Barril, S, Acebo, P, Millan-Billi, P, Luque, A, Sibila, O, Tarin, C, Tazi, A, Castillo, D, Hortelano, S. Bronchoalveolar cytokine profile differentiates Pulmonary Langerhans cell histiocytosis patients from other smoking-related interstitial lung diseases. RESPIRATORY RESEARCH. 2023; 24(1)DOI:10.1186/s12931-023-02622-z. PMID:38111019. IF:4.700(Q1/2D).
01/12/2023
Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population
Almonacid-Sánchez C., García-Cosío B., Trisán-Alonso A., Callejas-González F.J., Cisneros C., Martínez-Moragón E., Plaza Moral V., Vera E., Soto-Campos J.G., Martínez-Rivera C., Alcazar-Navarrete B., Urrutia Landa I., García-Rivero J.L., Padilla Galo A., Álvarez-Gutierrez F., Ramos-González J., Carretero-Gracia J.Á., Lluch I., Puente L., Andujar-Espinosa R., Pérez-de-Llano L.. Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(12)DOI:10.1016/j.arbres.2023.08.017. PMID:37865605. IF:8.700(Q1/1D).
01/11/2023
Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA
Plaza, V, Domínguez-Ortega, J, Alsina, DGS, Lo Re, D, Sicras-Mainar, A. Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA. Pharmaceuticals. 2023; 16(11)DOI:10.3390/ph16111609. PMID:38004474. IF:4.300(Q1/2D).
01/01/2023
Pulmonary Complications Following Hematopoietic Stem Cell Transplantation: Radiological Considerations
Franquet T., Giménez A., Mazzini S.. Pulmonary Complications Following Hematopoietic Stem Cell Transplantation: Radiological Considerations. Applied Psychology Readings: Selected Papers From The Singapore Conference On Applied Psychology 2022. 2023; DOI:10.1007/978-3-031-28797-8_6. PMID:. IF:(Q/D).
01/01/2023
Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19
Figueira-Gonçalves, JM, García-Bello, MA, Ramallo-Fariña, Y, Méndez, R, Campos, AL, González-Jiménez, P, Peces-Barba, G, Molina-Molina, M, España, PP, García, E, Domínguez-Pazos, SD, Clemente, MG, Panadero, C, de la Rosa-Carrillo, D, Sibila, O, Martínez-Pitarch, MD, Toledo-Pons, N, López-Ramirez, C, Almonte-Batista, W, Macías-Paredes, A, Redenes-Bonet, D, Pérez-Rodas, EN, Lázaro, J, Fernández, SQ, Cordovilla, R, Cano-Pumarega, I, Torres, A, Menendez, R. Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19. International Journal of Chronic Obstructive Pulmonary Disease. 2023; 18DOI:10.2147/COPD.S428316. PMID:37955022. IF:2.700(Q2/5D).
01/01/2023
Reply to "Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies"
Barroso, B, Valverde-Monge, M, Alobid,, Olaguibel, J, Rial, M, Quirce, S, Arismendi, E, Barranco, P, Betancor, D, Bobolea,, Cardaba, B, Carmona, MC, Curto, E, Dominguez-Ortega, J, Gonzalez-Barcala, F, Martinez-Rivera, C, Mahillo-Fernandez,, Munoz, X, Picado, C, Plaza,, Munoz, JR, Retes, LS, Valero, A, Delpozo,, Mullol, J, Sastre, J. Reply to "Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies". JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(6)DOI:10.18176/jiaci.0953. PMID:38095497. IF:6.700(Q1/2D).
01/08/2022
Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019
Fanciulli, C, Berenguer, J, Busca, C, Vivancos, MJ, Tellez, MJ, Dominguez, L, Domingo, P, Navarro, J, Santos, J, Iribarren, JA, Morano, L, Artero, A, Moreno, J, Rivero-Roman, A, Santos, I, Giner, L, Arminanzas, C, Montero, M, Manzardo, C, Cifuentes, C, Garcia, C, Galindo, MJ, Ferrero, OL, Sanz, J, de la Fuente, B, Rodriguez, C, Gaspar, G, Perez, L, Losa, JE, Force, L, Veloso, S, Martinez-Alfaro, E, Jarrin, I, De Miguel, M, Garcia, JG. Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019. HIV MEDICINE. 2022; 23(7)DOI:10.1111/hiv.13229. PMID:35037379. IF:3.000(Q3/7D).
01/07/2022
HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe
Amele, S, Sandri, AK, Rodger, A, Vandekerckhove, L, Benfield, T, Milinkovic, A, Duvivier, C, Stellbrink, HJ, Sambatakou, H, Chkhartishvili, N, Caldeira, L, Laguno, M, Domingo, P, Wandeler, G, Gisinger, M, Kuzovatova, E, Dragovic, G, Knysz, B, Matulionyte, R, Rockstroh, JK, Lundgren, JD, Mocroft, A, Peters, L. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe. HIV MEDICINE. 2022; 23(6)DOI:10.1111/hiv.13212. PMID:34882940. IF:3.000(Q3/7D).
01/07/2022
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study
Mocroft, A, Miro, JM, Wandeler, G, Llibre, JM, Boyd, A, van Bremen, K, Beniowski, M, Mikhalik, J, Cavassini, M, Maltez, F, Duvivier, C, Foppa, CU, Knysz, B, Bakowska, E, Kuzovatova, E, Domingo, P, Zagalo, A, Viard, JP, Degen, O, Milinkovic, A, Benfield, T, Peters, L. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study. HIV MEDICINE. 2022; 23(6)DOI:10.1111/hiv.13210. PMID:34889022. IF:3.000(Q3/7D).
01/02/2022
The endocrine role of brown adipose tissue: An update on actors and actions
Gavalda-Navarro, A, Villarroya, J, Cereijo, R, Giralt, M, Villarroya, F. The endocrine role of brown adipose tissue: An update on actors and actions. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS. 2022; 23(1)DOI:10.1007/s11154-021-09640-6. PMID:33712997. IF:8.200(Q1/1D).
12/01/2022
Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission
Calvet, J, Berenguer-Llergo, A, Gay, M, Massanella, M, Domingo, P, Llop, M, Sanchez-Jimenez, E, Arevalo, M, Carrillo, J, Albinana, N, Arauz-Garofalo, G, Orellana, C, Delgado, JF, Serrano, A, Llobell, A, Graell, E, Garcia-Manrique, M, Moreno, M, Galisteo, C, Casado, E, Navarro, N, Gomez, A, Garcia-Cirera, S, Rusinol, M, Costa, E, Clotet, B, Vilaseca, M, Blanco, J, Gratacos, J. Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-021-04683-w. PMID:35022497. IF:4.600(Q2/4D).
15/11/2021
Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial
Grau-Pujol, B, Camprubi-Ferrer, D, Marti-Soler, H, Fernandez-Pardos, M, Carreras-Abad, C, Velasco-de Andres, M, Ferrer, E, Muelas-Fernandez, M, Jullien, S, Barilaro, G, Ajanovic, S, Vera, I, Moreno, L, Gonzalez-Redondo, E, Cortes-Serra, N, Roldan, M, Artes-de Arcos, A, Mur, I, Domingo, P, Garcia, F, Guinovart, C, Munoz, J. Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial. Trials. 2021; 22(1)DOI:10.1186/s13063-021-05758-9. PMID:34781981. IF:2.728(Q4/8D).
01/11/2021
Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19
Alserawan, L, Penacoba, P, Echevarria, SEO, Castillo, D, Ortiz, E, Martinez-Martinez, L, Naranjo, EM, Domingo, P, Castellvi, I, Juarez, C, Mariscal, A. Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19. Diagnostics. 2021; 11(11)DOI:10.3390/diagnostics11111998. PMID:34829345. IF:3.992(Q2/4D).